$11.55
-0.03-0.26%
At close: Dec 16, 4:00 PM EST
$11.55
N/A
After Hours: 4:28 PM EST
Comments
Loading...
Contineum Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CTNM | Benzinga
Contineum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 5
EPS Estimate
$-0.450
Quarterly Revenue Estimate
$5.00M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Contineum Therapeutics using advanced sorting and filters.
Contineum Therapeutics (CTNM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $-0.45 | $-0.51 | 11.8 % |
| Q2 | 2025-08-05 | $-0.62 | $-0.47 | -31.9 % |
| Q1 | 2025-05-14 | $-0.62 | $-0.57 | -8.77 % |
| Q4 | 2025-03-06 | $-0.56 | $-0.44 | -27.3 % |
Contineum Therapeutics (CTNM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $0 | $5.00M | -100.0 % |
| Q2 | 2025-08-05 | $0 | $6.00M | -100.0 % |
FAQ
When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?
Contineum Therapeutics (CTNM) is scheduled to report earnings on March 5, 2026. The last reported earnings were for reported on October 30, 2025 for Q3.
What were the latest earnings per share (EPS) for Contineum Therapeutics (NASDAQ:CTNM)?
The Actual EPS was $-0.45, which beat the estimate of $-0.51.
What were Contineum Therapeutics’s (NASDAQ:CTNM) revenues?
The Actual Revenue was $0K, which missed the estimate of $5M.
Browse earnings estimates, EPS, and revenue on all stocks.
